Obayes, A. K., Hameed, H. A., & Mohammedsalih, A. I. (2024). Histological investigation for the effect of non-steroidal anti-inflammatory drug [diclofenac] on myocardium and lung of local breed Rabbit. Open Access Research Journal of Life Sciences, 8(2), 46–54.

Alsabri, M. A. H., Diab, R. A., Alqeeq, B. F., Rifai, M., Abouelmagd, K., Abo-Elnour, D. E., & Gamboa, L. L. (2025). Ketorolac as an analgesic in pediatric acute pain management: A systematic review and meta-analysis. Pediatric Emergency Care, 41(7), e34–e47.

Atefinezhad, M., Moghadamnia, A., Eftekhar, S. P., Moghadamnia, A. A., & Kazemi, S. (2022). Effect of Ketorolac on pharmacokinetics and pharmacodynamics of 5-fluorouracil: In vivo and in vitro study. Journal of Tropical Medicine, 2022(1), 5267861.

Avendaño, M. S., Martínez-Revelles, S., Aguado, A., Simões, M. R., González-Amor, M., Palacios, R., Guillem-Llobat, P., Vassallo, D. V, Vila, L., García-Puig, J., Beltrán, L. M., Alonso, M. J., Cachofeiro, M. V, Salaices, M., & Briones, A. M. (2016). Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension. British Journal of Pharmacology, 173(9), 1541–1555.

Babuin, L., & Jaffe, A. S. (2005). Troponin: The biomarker of choice for the detection of cardiac injury. Canadian Medical Association Journal, 173(10), 1191–1202.

Barachini, S., Ghelardoni, S., Varga, Z. V, Mehanna, R. A., Montt-Guevara, M. M., Ferdinandy, P., & Madonna, R. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity – An update. Vascular Pharmacology, 153, 107223.

Boarescu, I., & Boarescu, P.-M. (2024). Drug-induced myocardial infarction: A review of pharmacological triggers and pathophysiological mechanisms. Journal of Cardiovascular Development and Disease, 11(12), 406.

Boric, K., Dosenovic, S., Jelicic Kadic, A., Batinic, M., Cavar, M., Urlic, M., Markovina, N., & Puljak, L. (2017). Interventions for postoperative pain in children: An overview of systematic reviews. Pediatric Anesthesia, 27(9), 893–904.

Bormann, T., Maus, R., Stolper, J., Jonigk, D., Welte, T., Gauldie, J., Kolb, M., & Maus, U. A. (2021). Role of the COX2-PGE2 axis in S. pneumoniae-induced exacerbation of experimental fibrosis. American Journal of Physiology – Lung Cellular and Molecular Physiology, 320(3), L377–L392.

Bosch, D. J., Nieuwenhuijs-Moeke, G. J., van Meurs, M., Abdulahad, W. H., & Struys, M. M. R. F. (2022). Immune modulatory effects of nonsteroidal anti-inflammatory drugs in the perioperative period and their consequence on postoperative outcome. Anesthesiology, 136(5), 843–860.

Carneiro, R. M. F. de M., Cunha, R. S. da, Souza, L. M. de A., & Groppo, F. (2014). Preemptive analgesia of dexamethasone as compared to ketorolac tromethamine in simple tooth extractions. Revista Dor, 15(2), 83–86.

Chen, Q., Wang, Q., Zhu, J., Xiao, Q., & Zhang, L. (2018). Reactive oxygen species: Key regulators in vascular health and diseases. British Journal of Pharmacology, 175(8), 1279–1292.

Cheng, H., Huang, H., Guo, Z., Chang, Y., & Li, Z. (2021). Role of prostaglandin E2 in tissue repair and regeneration. Theranostics, 11(18), 8836–8854.

Claar, D., Hartert, T. V., & Peebles Jr., R. S. (2015). The role of prostaglandins in allergic lung inflammation and asthma. Expert Review of Respiratory Medicine, 9(1), 55–72.

das Dores Lopes, P., de Assis, N., de Araújo, N. F., Moreno, O. L. M., de Oliveira Santana Jorge, K. T., e Castor, M. G. M., Teixeira, M. M., Soriani, F. M., dos Santos Aggum Capettini, L., Bonaventura, D., & de Assis Cau, S. B. (2022). COX/iNOS dependence for angiotensin-II-induced endothelial dysfunction. Peptides, 157, 170863.

Dolanbay, T., Makav, M., Gul, H. F., & Karakurt, E. (2021). The effect of diclofenac sodium intoxication on the cardiovascular system in rats. The American Journal of Emergency Medicine, 46, 560–566.

Elbrønd, V. S., Thomsen, M. B., Isaksen, J. L., Lunde, E. D., Vincenti, S., Wang, T., Tranum-Jensen, J., & Calloe, K. (2023). Intramural Purkinje fibers facilitate rapid ventricular activation in the equine heart. Acta Physiologica, 237(3), e13925.

Esparza-Villalpando, V., Ortiz-Barroso, G., & Masuoka-Ito, D. (2024). Evidence-based safety profile of oral ketorolac in adults: Systematic review and meta-analysis. Pharmacology Research and Perspectives, 12(6), e70033.

Forestell, B., Sabbineni, M., Sharif, S., Chao, J., & Eltorki, M. (2023). Comparative effectiveness of Ketorolac dosing strategies for emergency department patients with acute pain. Annals of Emergency Medicine, 82(5), 615–623.

Gokul, A. J., Chandur, V. K., & Shabarya, A. R. (2023). Non-selective Cox inhibitor NSAID’s induced nephropathy: A systematic review. International Journal in Pharmaceutical Sciences, 1(12), 433–440.

Guan, J., Feng, N., Yang, K., Abudouaini, H., & Liu, P. (2024). The efficacy and safety of Ketorolac for postoperative pain management in lumbar spine surgery: A meta-analysis of randomized controlled trials. Systematic Reviews, 13(1), 275.

Irmak, K., Tüten, N., Karaoglu, G., Madazli, R., Tüten, A., Malik, E., & Güralp, O. (2021). Evaluation of cord blood creatine kinase (CK), cardiac troponin T (cTnT), N-terminal-pro-B-type natriuretic peptide (NT-proBNP), and s100B levels in nonreassuring foetal heart rate. The Journal of Maternal-Fetal and Neonatal Medicine, 34(8), 1249–1254.

Isiordia-Espinoza, M. A., Alonso-Castro, Á. J., Serafín-Higuera, N., Castañeda-Santana, D. I., de la Rosa Coronado, M., & Bologna-Molina, R. E. (2022). Postoperative administration of Ketorolac compared to other drugs for pain control after third molar surgery: A meta-analysis of double-blind, randomized, clinical trials. British Journal of Clinical Pharmacology, 88(6), 2591–2604.

Katusic, Z. S., Santhanam, A. V., & He, T. (2012). Vascular effects of prostacyclin: Does activation of PPARδ play a role? Trends in Pharmacological Sciences, 33(10), 559–564.

Koohsari, M., Shaki, F., & Jahani, D. (2016). Protective effects of edaravone against methamphetamine-induced cardiotoxicity. Brazilian Archives of Biology and Technology, 59, e16160093.

Lefchak, B., Morgan, D., Finch, M., Madhok, M., & Raschka, M. (2024). Ketorolac dose ceiling effect for pediatric headache in the emergency department. The Journal of Pediatric Pharmacology and Therapeutics, 29(5), 494–500.

Lin, Y.-N., Ibrahim, A., Marbán, E., & Cingolani, E. (2021). Pathogenesis of arrhythmogenic cardiomyopathy: Role of inflammation. Basic Research in Cardiology, 116(1), 39.

Liu, N., Guan, Y., Zhou, C., Wang, Y., Ma, Z., & Yao, S. (2022). Pulmonary and systemic toxicity in a rat model of pulmonary alveolar proteinosis induced by indium-tin oxide nanoparticles. International Journal of Nanomedicine, 17, 713–731.

Lu, H., Lai, K., Lin, S., & Dang, G. (2025). Anaphylactic shock induced by intravenous ketorolac: A case report. Heliyon, 11(3), e42236.

Maher, T. M., Evans, I. C., Bottoms, S. E., Mercer, P. F., Thorley, A. J., Nicholson, A. G., Laurent, G. J., Tetley, T. D., Chambers, R. C., & McAnulty, R. J. (2010). Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine, 182(1), 73–82.

McDonald, E., Winters, B., Nicholson, K., Shakked, R., Raikin, S., Pedowitz, D. I., & Daniel, J. N. (2018). Effect of postoperative Ketorolac administration on bone healing in ankle fracture surgery. Foot and Ankle International, 39(10), 1135–1140.

Miao, Y., Yang, Y., Li, X., Meng, L., Mao, J., Zhang, J., Gao, J., Yang, C., Gu, X., Zhou, H., & Zhang, Y. (2023). Imrecoxib attenuates bleomycin-induced pulmonary fibrosis in mice. Heliyon, 9(11), e20914.

Milutinović, A., & Zorc-Pleskovič, R. (2012). Glycogen accumulation in cardiomyocytes and cardiotoxic effects after 3NPA treatment. Bosnian Journal of Basic Medical Sciences, 12(1), 15–19.

Mohammad, N., Darweesh, O., & Merkhan, M. (2025). The impact of disease-modifying medications on the lipid profile of patients with ischemic heart disease. Georgian Medical News, 363, 175–178.

Moro, M. G., Sanchez, P. K. V., Gevert, M. V., Baller, E. M., Tostes, A. F., Lupepsa, A. C., Baglie, S., & Franco, G. C. N. (2016). Gastric and renal effects of COX-2 selective and non-selective NSAIDs in rats receiving low-dose aspirin therapy. Brazilian Oral Research, 30(1), e127.

Nguyen, B. L., Fishbein, M. C., Chen, L. S., Chen, P.-S., & Masroor, S. (2009). Histopathological substrate for chronic atrial fibrillation in humans. Heart Rhythm, 6(4), 454–460.

Obayes, A. K., Mutar, W. M., Ayub, R. H., & Mohammed, S. A. (2020). Histological study of the effect of isoxicam on ovary of albino mice mus musculus. Indian Journal of Forensic Medicine and Toxicology, 14(2), 520–525.

Okwakpam, F. N., Dokubo, A., Monanu, M. O., & Uahomo, P. O. (2023). Cardioprotective effects of apocynin and curcumin against Diclofenac-induced cardiotoxicity in male Wistar rats via inhibition of oxidative stress. Scholars International Journal of Biochemistry, 6(07), 86–98.

Pászti, B., Prorok, J., Magyar, T., Árpádffy-Lovas, T., Györe, B., Topál, L., Gazdag, P., Szlovák, J., Naveed, M., Jost, N., Nagy, N., Varró, A., Virág, L., & Koncz, I. (2021). Cardiac electrophysiological effects of ibuprofen in dog and rabbit ventricular preparations: Possible implication to enhanced proarrhythmic risk. Canadian Journal of Physiology and Pharmacology, 99(1), 102–109.

Probst, C. K., Montesi, S. B., Medoff, B. D., Shea, B. S., & Knipe, R. S. (2020). Vascular permeability in the fibrotic lung. European Respiratory Journal, 56(1), 1900100.

Ricciotti, E., Haines, P. G., Chai, W., & FitzGerald, G. A. (2024). Prostanoids in cardiac and vascular remodeling. Arteriosclerosis, Thrombosis, and Vascular Biology, 44(3), 558–583.

S, D. L., B, V. G., & Murali, V. (2024). From prescription to pollution: The ecological consequences of NSAIDs in aquatic ecosystems. Toxicology Reports, 13, 101775.

Severino, P., D’Amato, A., Prosperi, S., Fanisio, F., Birtolo, L. I., Costi, B., Netti, L., Chimenti, C., Lavalle, C., Maestrini, V., Mancone, M., & Fedele, F. (2021). Myocardial tissue characterization in heart failure with preserved ejection fraction: From histopathology and cardiac magnetic resonance findings to therapeutic targets. International Journal of Molecular Sciences, 22(14), 7650.

Shalabi, M., Mahran, A. H., & Elsewif, T. (2024). Effect of submucosal cryotherapy compared with steroids and NSAIDs injections on Substance P and interleukin 6 pulpal release in experimentally induced pulpal inflammation in rabbits. Journal of Applied Oral Science, 32, e20240017.

Sorodoc, V., Sirbu, O., Lionte, C., Haliga, R. E., Stoica, A., Ceasovschih, A., Petris, O. R., Constantin, M., Costache, I. I., Petris, A. O., Morariu, P. C., & Sorodoc, L. (2022). The value of troponin as a biomarker of chemotherapy-induced cardiotoxicity. Life, 12(8), 1183.

Szczuko, M., Kozioł, I., Kotlęga, D., Brodowski, J., & Drozd, A. (2021). The role of thromboxane in the course and treatment of ischemic stroke: Review. International Journal of Molecular Sciences, 22(21), 11644.

Tashiro, J., Rubio, G. A., Limper, A. H., Williams, K., Elliot, S. J., Ninou, I., Aidinis, V., Tzouvelekis, A., & Glassberg, M. K. (2017). Exploring animal models that resemble idiopathic pulmonary fibrosis. Frontiers in Medicine, 4, 118.

Tejado, B. S. M., & Jou, C. (2018). Histopathology in HCM. Global Cardiology Science and Practice, 2018(3), 20.

Tjenggal, K. A., Sinuraya, R. K., Rahayu, C., & Abdulah, R. (2021). NSAID-induced adverse drug reaction: Mechanism and management. Indian Journal of Forensic Medicine and Toxicology, 15(2), 207.

Uddin, M. B., Hossain, A. M., Alam, M. M., & Hossain, A. S. (2008). Ketorolac and pethidine in post-operative pain relief. Bangladesh Journal of Pharmacology, 2(1), 498.

Van-Seuningen, I., & Davril, M. (1992). A rapid periodic acid-Schiff staining procedure for the detection of glycoproteins using the phastsystem. Electrophoresis, 13(1), 97–99.

Vupputuri, A., Sekhar, S., Krishnan, S., Venugopal, K., & Natarajan, K. U. (2015). Heart-type fatty acid-binding protein (H-FABP) as an early diagnostic biomarker in patients with acute chest pain. Indian Heart Journal, 67(6), 538–542.

Wang, Y., Wang, M., Samuel, C. S., & Widdop, R. E. (2022). Preclinical rodent models of cardiac fibrosis. British Journal of Pharmacology, 179(5), 882–899.

Zahkouk, S. A., El-Gendy, A. M., Eid, F. A., El-Tahway, N. A., & El-Shamy, S. A. (2015). Physiological and histological studies on the heart of male albino rats exposed to electromagnetic field and the protective role of silymarin and/or vitamin E. The Egyptian Journal of Hospital Medicine, 58, 94–108.

Zhou, X., Wang, Z., Wang, Y., Xu, G., Luo, M., Zhang, M., & Li, Y. (2025). Rutin ameliorates LPS-induced acute lung injury in mice by inhibiting the cGAS-STING-NLRP3 signaling pathway. Frontiers in Pharmacology, 16, 1590096.